164 related articles for article (PubMed ID: 33655983)
1. Preoperative disseminated intravascular coagulation complicated by thoracic aortic aneurysm treated using recombinant human soluble thrombomodulin: A case report.
Tanigawa Y; Yamada Y; Nakamura K; Yamashita T; Nakagawachi A; Sakaguchi Y
Medicine (Baltimore); 2021 Mar; 100(9):e25044. PubMed ID: 33655983
[TBL] [Abstract][Full Text] [Related]
2. The effect of recombinant human soluble thrombomodulin on disseminated intravascular coagulation in an abdominal aortic aneurysm.
Hoshina K; Shigematsu K; Hosaka A; Okamoto H; Miyata T; Watanabe T
Blood Coagul Fibrinolysis; 2014 Jun; 25(4):389-91. PubMed ID: 24378974
[TBL] [Abstract][Full Text] [Related]
3. Intermittent administration of recombinant human soluble thrombomodulin successfully controlled chronic disseminated intravascular coagulation in a patient with dissecting aortic aneurysm on an outpatient basis.
Iyama S; Sato T; Murase K; Kamihara Y; Ono K; Kikuchi S; Takada K; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):548-50. PubMed ID: 22732250
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis.
Kato H; Hagihara M; Asai N; Umemura T; Hirai J; Mori N; Yamagishi Y; Iwamoto T; Mikamo H
Thromb Res; 2023 Jun; 226():165-172. PubMed ID: 37182388
[TBL] [Abstract][Full Text] [Related]
5. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Human Soluble Thrombomodulin Contributes to a Reduction In-Hospital Mortality of Acute Cholangitis with Disseminated Intravascular Coagulation: A Propensity Score Analyses of a Japanese Nationwide Database.
Tarasawa K; Fujimori K; Fushimi K
Tohoku J Exp Med; 2020 Sep; 252(1):53-61. PubMed ID: 32879147
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
Yamakawa K; Ogura H; Fujimi S; Morikawa M; Ogawa Y; Mohri T; Nakamori Y; Inoue Y; Kuwagata Y; Tanaka H; Hamasaki T; Shimazu T
Intensive Care Med; 2013 Apr; 39(4):644-52. PubMed ID: 23361628
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients.
Miyoshi S; Ito R; Katayama H; Dote K; Aibiki M; Hamada H; Okura T; Higaki J
Drug Des Devel Ther; 2014; 8():1211-9. PubMed ID: 25214765
[TBL] [Abstract][Full Text] [Related]
11. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of recombinant thrombomodulin administration on disseminated intravascular coagulation due to severe acute cholangitis (Recover-AC study).
Ogura T; Eguchi T; Nakahara K; Kanno Y; Omoto S; Itonaga M; Kuroda T; Hakoda A; Ikeoka S; Takagi M; Okada A; Sato J; Morita R; Michikawa Y; Ito K; Koshita S; Takenaka M; Kitano M; Koizumi M; Higuchi K
J Hepatobiliary Pancreat Sci; 2023 Feb; 30(2):221-228. PubMed ID: 34021720
[TBL] [Abstract][Full Text] [Related]
13. Factors Determining the Efficacy of Recombinant Human Thrombomodulin in the Treatment of Sepsis-Induced Disseminated Intravascular Coagulation.
Kotake K; Hongo T; Tahira A; Niimi N; Haisa I; Kawakami Y
Biol Pharm Bull; 2021 May; 44(5):605-610. PubMed ID: 33612566
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study.
Yoshihara M; Uno K; Tano S; Mayama M; Ukai M; Kondo S; Kokabu T; Kishigami Y; Oguchi H
Crit Care; 2015 Oct; 19():369. PubMed ID: 26481315
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis.
Ogawa Y; Yamakawa K; Ogura H; Kiguchi T; Mohri T; Nakamori Y; Kuwagata Y; Shimazu T; Hamasaki T; Fujimi S
J Trauma Acute Care Surg; 2012 May; 72(5):1150-7. PubMed ID: 22673239
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
J Thromb Haemost; 2015 Jan; 13(1):31-40. PubMed ID: 25393713
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis.
Yamakawa K; Aihara M; Ogura H; Yuhara H; Hamasaki T; Shimazu T
J Thromb Haemost; 2015 Apr; 13(4):508-19. PubMed ID: 25581687
[TBL] [Abstract][Full Text] [Related]
18. Recombinant soluble thrombomodulin for postoperative disseminated intravascular coagulation.
Hashimoto D; Chikamoto A; Miyanari N; Ohara C; Kuramoto M; Horino K; Ohshima H; Baba H
J Surg Res; 2015 Aug; 197(2):405-11. PubMed ID: 25972310
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC.
Aota T; Wada H; Yamashita Y; Matsumoto T; Ohishi K; Suzuki K; Imai H; Usui M; Isaji S; Katayama N
Int J Hematol; 2016 Feb; 103(2):173-9. PubMed ID: 26590919
[TBL] [Abstract][Full Text] [Related]
20. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
Yoshimura J; Yamakawa K; Ogura H; Umemura Y; Takahashi H; Morikawa M; Inoue Y; Fujimi S; Tanaka H; Hamasaki T; Shimazu T
Crit Care; 2015 Mar; 19(1):78. PubMed ID: 25883031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
